Catalysts and events · 2026-09-09
Everything the Opportunity Map and Intelligence Feed published for this date.
DateCardAvg 5d
- 2026-09-09Western Digital Generates $3.51B FY2026 FCF and Guides Q1 Revenue to $4.1BSTX WDC-13.54%
- 2026-09-09Liberty Latin America Director Buys $10M in Preference SharesLILA LILAK+1.04%
- 2026-09-09Lockheed Martin Upgraded to Buy at UBS on 3.2x Book-to-Bill and Missile DemandITA LMT+0.27%
- 2026-09-09Vistra Drops 30% to $154 as PJM Scrutiny and Outages Compress ValuationSPY VST-1.10%
- 2026-09-09Vistra Pulls Back 30% on Battery Outages and PJM Interconnection ScrutinyVST XLU-3.77%
- 2026-09-09Western Digital Concludes FY2026 With $3.51B Free Cash Flow and $500M Net CashSTX WDC-13.54%
- 2026-09-09VoIP-Pal Files Third Amended Antitrust Complaint Against Major TelecomsT TMUS VZ-0.61%
- 2026-09-09Rivian CFO Claire McDonough Departs for GE VernovaGEV RIVN-2.73%
- 2026-09-09Rivian CFO Claire McDonough Departs for GE Vernova After Six-Year TenureGEV RIVN-2.73%
- 2026-09-09Lockheed Martin Upgraded at UBS on 3.2x Book-to-Bill and F-35 Sales GrowthLMT SPY+0.67%
- 2026-09-09Western Digital posts $3.51B FY2026 FCF, guides Q1 FY2027 EPS to $4.00STX WDC-13.54%
- 2026-09-09TSMC Reaches Record Gross Margins Supported by Over 70% Global Foundry ShareNVDA TSM-4.21%
- 2026-09-09Lockheed Martin Upgraded to Buy at UBS on 3.2x Book-to-Bill and F-35 BacklogITA LMT+0.27%
- 2026-09-09Western Digital Ends FY2026 With $3.51B Free Cash Flow and $4.00 Q1 EPS OutlookSTX WDC-13.54%
- 2026-09-09DENTSPLY SIRONA Beats Q2 Adjusted EPS at $0.52 and Reaffirms GuidanceXRAY-5.41%
- 2026-09-09Adobe sets Q3 FY2026 report with $6.67B-$6.72B revenue guidanceADBE-1.71%
- 2026-09-09Dentsply Sirona Tops Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY2026 GuidanceALGN XRAY-5.41%
- 2026-09-09Adobe Prepares Q3 Report With $6.67B-$6.72B Revenue and $500M AI ARR Run RateADBE MSFT-0.99%
- 2026-09-09Adobe Prepares Q3 Report with Revenue Target of $6.67B to $6.72BADBE-1.71%
- 2026-09-09CRISPR Therapeutics Expands Casgevy Label to Pediatric Patients as Q2 Sales Hit $76MCRSP VRTX-1.51%
- 2026-09-09Braze Delivers Q2 EPS of $0.19 on $227.23M Revenue, Beating ConsensusBRZE+4.83%
- 2026-09-09Broadcom Positioned for 60% Custom AI ASIC Share by 2027 as Hyperscalers DiversifyAVGO MRVL-4.54%
- 2026-09-09Adobe Ahead of Q3 FY2026: Revenue Guidance Set at $6.67B to $6.72BADBE SPY-1.41%
- 2026-09-09Adobe Prepares Q3 FY2026 Release With $6.67B-$6.72B Revenue Target and $500M AI ARRADBE MSFT-0.99%
- 2026-09-09Argan Posts 61.5% Revenue Surge on Power Segment Expansion and Margin GainsAGX PWR-1.66%
- 2026-09-09Dentsply Sirona Beats Q2 EPS at $0.52 and Reaffirms FY26 Sales OutlookXRAY-5.41%
- 2026-09-09CRISPR Therapeutics Casgevy Sales Surge 78% QoQ to $76M Following FDA ExpansionCRSP VRTX-1.51%
- 2026-09-09Broadcom Positioned for 60% Custom AI Chip Share with $230B FY28 Revenue OutlookAVGO MRVL NVDA-4.49%
- 2026-09-09Argan Q2 Power Revenue Rises 52.9% with 22.4% Gross MarginAGX UNG+0.30%
- 2026-09-09Broadcom Projected at 60% Custom AI Chip Share by 2027 vs Marvell 20-25%AVGO MRVL-4.54%
- 2026-09-09Dentsply Sirona Beats Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY26 OutlookALGN XRAY-5.41%
- 2026-09-09Adobe Previews Q3 Results with $500M AI ARR Ahead of Sept 10 ReportADBE SPY-1.41%
- 2026-09-09CRISPR Therapeutics Expands Casgevy Label to Pediatric Patients as Q2 Sales Hit $76MCRSP VRTX-1.51%
- 2026-09-09CRISPR Therapeutics Gains FDA Pediatric Approval for Casgevy as Sales Hit $76MCRSP VRTX-1.51%
- 2026-09-09Dentsply Sirona Beats Q2 EPS at $0.52 and Affirms FY2026 Sales GuidanceALGN XRAY-5.41%
- 2026-09-09NextEra Secures $1.9B DOE Loan Guarantee to Restart Iowa Nuclear FacilityGOOGL NEE
- 2026-09-09Braze Q2 FY2026 Revenue Reaches $227.23M Beating Estimates With $0.19 EPSBRZE+4.83%
- 2026-09-09Broadcom projected to capture 60% custom AI chip share vs Marvell 20-25%AVGO MRVL-4.54%
- 2026-09-09Nucor Q3 Projections Forecast 107.6% EPS Growth Despite Steel Price PressuresCPER NUE-5.99%
- 2026-09-09CRISPR Therapeutics Casgevy Revenue Surges 78% QoQ to $76M on Pediatric LabelCRSP VRTX XBI-2.38%
- 2026-09-09CRISPR Therapeutics Expands Casgevy Label to Pediatric Patients as Q2 Sales Hit $76MCRSP VRTX-1.51%
- 2026-09-09Fed Hike Odds Cross 60% as Digital Assets and Rate Sensitives SoftenDXY SPY TLT-1.07%
- 2026-09-09Argan Q2 Fiscal 2027 Earnings Surge on 52.9% Power Construction GrowthAGX PWR-1.66%
- 2026-09-09Bureau Veritas Prices EUR 700M Senior Bond Maturing Sept 2034BVVBY
- 2026-09-09PACS Group to Acquire 32 Florida Facilities with 4,049 BedsOHI PACS
- 2026-09-09Braze Beats Q2 Expectations With EPS of $0.19 on $227.2M RevenueBRZE+4.83%
- 2026-09-09Braze Delivers Q2 EPS Beat at $0.19 on Revenue of $227.23MBRZE+4.83%
- 2026-09-09Dentsply Sirona Tops Q2 EPS at $0.52 and Affirms Full-Year $3.5B-$3.6B Sales GuidanceXRAY-5.41%
- 2026-09-09CRISPR Therapeutics Expands Casgevy Label and Posts 78% Sequential Revenue GrowthCRSP VRTX-1.51%
- 2026-09-09CRISPR Therapeutics Casgevy Q2 Sales Surge 78% QoQ to $76M on Pediatric LabelCRSP VRTX-1.51%
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.